Evidence map›Paper›PMID 33937874›Full record

ArticleSTAR protocols2021

Selective immunocapture and light-controlled traceless release of transiently caged proteins.

Rasa Rakauskaitė, Giedrė Urbanavičiūtė, Martynas Simanavičius, Aurelija Žvirblienė, Saulius Klimašauskas

Abstract read
In one paragraph

Article in STAR protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rasa RakauskaitėInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius LT-10257, Lithuania.
Giedrė UrbanavičiūtėInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius LT-10257, Lithuania.
Martynas SimanavičiusInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius LT-10257, Lithuania.
Aurelija ŽvirblienėInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius LT-10257, Lithuania.
Saulius KlimašauskasInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius LT-10257, Lithuania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 4,5-dimethoxy-2-nitrobenzyl (DMNB) photocaging group introduced into small biomolecules, peptides, oligonucleotides, and proteins is commonly used for spatiotemporal control of chemical and biological processes. Here, we describe the use of a DMNB-selective monoclonal antibody for non-covalent capture of chemically or biosynthetically produced proteins containing surface-exposed DMNB caging groups followed by light-controlled traceless decaging and release of the bound proteins into solution for a variety of downstream applications. For complete details on the use and execution of this protocol, please refer to Rakauskaitė et al. (2020).

Indexed as

LightAntibodiesFluoresceinsPeptidesAntibodiesFluoresceinsPeptidesAntibodyMolecular/Chemical ProbesProtein Biochemistry

Identifiers

PMID33937874
PMCPMC8076704

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.